ПРЕДУПРЕЖДЕНИЕ О СРОКОМ CELSIUS: Bragar Eagel & Squire, PC напоминает инвесторам, что против Celsius Network LLC и других ответчиков был подан коллективный иск, и призывает инвесторов связаться с фирмой PlatoBlockchain Data Intelligence. Вертикальный поиск. Ай.

CELSIUS DEADLINE ALERT: Bragar Eagel & Squire, PC, напоминает инвесторам, что против Celsius Network LLC и других ответчиков был подан коллективный иск, и призывает инвесторов обращаться в фирму

НЬЮ-ЙОРК– (БИЗНЕС ПРОВОД) -# Действие–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Celsius Network LLC, Celsius Lending LLC, Celsius KeyFi LLC, Alexander Mashinsky, Shlomi Leon, David Base, and Alan Jeffrey Carr in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Celsius securities between February 9, 2018 and July 13, 2022, both dates inclusive (the “Class Period”). Investors have until September 13, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Нажмите здесь участвовать в акции.

Celsius is a financial services company that generates revenue through cryptocurrency trading, lending, and borrowing, the sale of its unregistered securities, as well as engaging in proprietary trading.

The price of CEL Tokens went from a high of $7.73 on June 3, 2021, to a low of $0.28 just over a year later on June 12, 2021, in the wake of the June Crisis and Celsius freezing its investors accounts.

The complaint alleges that Defendants violated provisions of the Exchange Act by carrying out a plan, scheme, and course of conduct that Celsius intended to and did deceive retail investors and thereby caused them to purchase Celsius Financial Products at artificially inflated prices; endorsed false statements they knew or recklessly should have known were materially misleading, and made untrue statements of material fact and omitted to state material facts necessary to make the statements made not misleading.

The complaint further alleges that Celsius and its affiliates, along with the Individual Defendants, also violated provisions of the Securities Act by selling non-exempt securities without registering it. The complaint alleges that Celsius and Individual Defendants violated provisions of the Securities Act by also participating in Celsius’ failure to register the Celsius Financial Products. The complaint alleges that the Defendants violated provisions of the New Jersey Common Law by possessing the monetary value of Celsius Financial Products of inflated value which rightfully belongs to the Plaintiff and members of the Class.

If you purchased or otherwise acquired Celsius shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at research@bespc.com, по телефону (212) 355-4648 или по заполнив эту контактную форму. Для вас нет никаких затрат или обязательств.

Информация о Bragar Eagel & Squire, PC:

Bragar Eagel & Squire, PC - признанная на национальном уровне юридическая фирма с офисами в Нью-Йорке, Калифорнии и Южной Каролине. Фирма представляет индивидуальных и институциональных инвесторов в коммерческих судебных процессах, судебных процессах по ценным бумагам, производным финансовым инструментам и других сложных судебных процессах в государственных и федеральных судах по всей стране. Для получения дополнительной информации о фирме посетите www.bespc.com. Адвокатская реклама. Предыдущие результаты не гарантируют аналогичных результатов.

Контакты

Брагар Игел и оруженосец, ПК

Брэндон Уокер, эсквайр.

Мелисса Фортунато, эсквайр.

(212) 355-4648

research@bespc.com
www.bespc.com

Отметка времени:

Больше от Финтех Новости

Alnylam объявляет об одобрении FDA препарата AMVUTTRA™ (вутрисиран), терапевтического средства РНК-интерференции для лечения полинейропатии наследственного транстиретин-опосредованного амилоидоза у взрослых

Исходный узел: 1367278
Отметка времени: Июнь 13, 2022